ppdi: +7 to $41@high, close @38

Drug company Pharmaceutical Product Development Inc. said on Monday its first-quarter profit increased 27 percent, driven by a nearly 23-percent rise in sales.
Income for the quarter was $41.8 million, or 35 cents per share, up from $32.9 million, or 29 cents per share, a year ago. Revenue for the quarter increased to $299.4 million, up from $244.1 million last year.

Analysts polled by Thomson Financial expected the company to earn, on average, 35 cents per share on $274.8 million in revenue.

rsas: +4 to 20.55

RSA Security (RSAS:Nasdaq - commentary - research - Cramer's Take) shares moved higher after the security technology company beat Wall Street's first-quarter earnings expectations. The company's net profit fell to $5.3 million, or 7 cents a share, from $7.2 million, or 10 cents a share a year ago, but the year-earlier results didn't include stock-option costs. Excluding some items, the company earned $10.5 million, or 14 cents a share. Revenue grew to $87.5 million from $75.6 million. Analysts had forecast earnings of 13 cents a share, before items, on revenue of $85.5 million.

For the second quarter, RSA projects revenue of $88 million to $92 million and earnings before items of 14 cents to 16 cents a share. Analysts, on average, predicted earnings of 14 cents a share and revenue of $87.6 million. Shares rose 68 cents, or 4%, to $17.50 in after-hours trading.

ufpi +8 to 72

Shares of Universal Forest Products (UFPI:Nasdaq - commentary - research - Cramer's Take) climbed in after-hours trading Monday after the building materials company beat Wall Street's first-quarter earnings expectations.

The company earned $15.9 million, or 82 cents a share, compared with $9.2 million, or 49 cents a share, a year ago. Analysts surveyed by Thomson First Call were expecting the company to post earnings of 63 cents a share. Revenue rose 24% to $665.6 million, surpassing Wall Street's expectation of $573 million. In light of the first-quarter results, Universal Forest Products raised its full-year earnings growth target to 15% to 20% from 10% to 15%. The company reaffirmed its unit sales projection for 10% to 15% growth in 2006. Shares rose $4.30, or 6.7%, to $68.25 in after-hours trading.